Lipid Metabolism Disorders in the Comorbid Course of Nonalcoholic Fatty Liver Disease and Chronic Obstructive Pulmonary Disease

Non-alcoholic fatty liver disease (NAFLD) is currently among the most common liver diseases. Unfavorable data on the epidemiology of metabolic syndrome and obesity have increased the attention of clinicians and researchers to the problem of NAFLD. The research results allow us to emphasize the syste...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Stanislav Kotlyarov, Aleksei Bulgakov
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/3e0208c3b72f43ba94f5cd4e667235cd
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:3e0208c3b72f43ba94f5cd4e667235cd
record_format dspace
spelling oai:doaj.org-article:3e0208c3b72f43ba94f5cd4e667235cd2021-11-25T17:09:58ZLipid Metabolism Disorders in the Comorbid Course of Nonalcoholic Fatty Liver Disease and Chronic Obstructive Pulmonary Disease10.3390/cells101129782073-4409https://doaj.org/article/3e0208c3b72f43ba94f5cd4e667235cd2021-11-01T00:00:00Zhttps://www.mdpi.com/2073-4409/10/11/2978https://doaj.org/toc/2073-4409Non-alcoholic fatty liver disease (NAFLD) is currently among the most common liver diseases. Unfavorable data on the epidemiology of metabolic syndrome and obesity have increased the attention of clinicians and researchers to the problem of NAFLD. The research results allow us to emphasize the systemicity and multifactoriality of the pathogenesis of liver parenchyma lesion. At the same time, many aspects of its classification, etiology, and pathogenesis remain controversial. Local and systemic metabolic disorders are also a part of the pathogenesis of chronic obstructive pulmonary disease and can influence its course. The present article analyzes the metabolic pathways mediating the links of impaired lipid metabolism in NAFLD and chronic obstructive pulmonary disease (COPD). Free fatty acids, cholesterol, and ceramides are involved in key metabolic and inflammatory pathways underlying the pathogenesis of both diseases. Moreover, inflammation and lipid metabolism demonstrate close links in the comorbid course of NAFLD and COPD.Stanislav KotlyarovAleksei BulgakovMDPI AGarticlenon-alcoholic fatty liver diseaselipid metabolismmetabolismchronic obstructive pulmonary diseaseBiology (General)QH301-705.5ENCells, Vol 10, Iss 2978, p 2978 (2021)
institution DOAJ
collection DOAJ
language EN
topic non-alcoholic fatty liver disease
lipid metabolism
metabolism
chronic obstructive pulmonary disease
Biology (General)
QH301-705.5
spellingShingle non-alcoholic fatty liver disease
lipid metabolism
metabolism
chronic obstructive pulmonary disease
Biology (General)
QH301-705.5
Stanislav Kotlyarov
Aleksei Bulgakov
Lipid Metabolism Disorders in the Comorbid Course of Nonalcoholic Fatty Liver Disease and Chronic Obstructive Pulmonary Disease
description Non-alcoholic fatty liver disease (NAFLD) is currently among the most common liver diseases. Unfavorable data on the epidemiology of metabolic syndrome and obesity have increased the attention of clinicians and researchers to the problem of NAFLD. The research results allow us to emphasize the systemicity and multifactoriality of the pathogenesis of liver parenchyma lesion. At the same time, many aspects of its classification, etiology, and pathogenesis remain controversial. Local and systemic metabolic disorders are also a part of the pathogenesis of chronic obstructive pulmonary disease and can influence its course. The present article analyzes the metabolic pathways mediating the links of impaired lipid metabolism in NAFLD and chronic obstructive pulmonary disease (COPD). Free fatty acids, cholesterol, and ceramides are involved in key metabolic and inflammatory pathways underlying the pathogenesis of both diseases. Moreover, inflammation and lipid metabolism demonstrate close links in the comorbid course of NAFLD and COPD.
format article
author Stanislav Kotlyarov
Aleksei Bulgakov
author_facet Stanislav Kotlyarov
Aleksei Bulgakov
author_sort Stanislav Kotlyarov
title Lipid Metabolism Disorders in the Comorbid Course of Nonalcoholic Fatty Liver Disease and Chronic Obstructive Pulmonary Disease
title_short Lipid Metabolism Disorders in the Comorbid Course of Nonalcoholic Fatty Liver Disease and Chronic Obstructive Pulmonary Disease
title_full Lipid Metabolism Disorders in the Comorbid Course of Nonalcoholic Fatty Liver Disease and Chronic Obstructive Pulmonary Disease
title_fullStr Lipid Metabolism Disorders in the Comorbid Course of Nonalcoholic Fatty Liver Disease and Chronic Obstructive Pulmonary Disease
title_full_unstemmed Lipid Metabolism Disorders in the Comorbid Course of Nonalcoholic Fatty Liver Disease and Chronic Obstructive Pulmonary Disease
title_sort lipid metabolism disorders in the comorbid course of nonalcoholic fatty liver disease and chronic obstructive pulmonary disease
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/3e0208c3b72f43ba94f5cd4e667235cd
work_keys_str_mv AT stanislavkotlyarov lipidmetabolismdisordersinthecomorbidcourseofnonalcoholicfattyliverdiseaseandchronicobstructivepulmonarydisease
AT alekseibulgakov lipidmetabolismdisordersinthecomorbidcourseofnonalcoholicfattyliverdiseaseandchronicobstructivepulmonarydisease
_version_ 1718412642345811968